Zeev's Turnips Patch-No Politics (ZEEV)

[XenaLives]

Bio insanity - an example. ISIS down to the lowest in eight days on good news. It was take down two weeks ago from steady trading at $8 to just above $6 by a hearsay report by an anylist of trial failure on a blinded study. Stock recovered and has been trading steady at around $6.90 until today's good news, which turned out to be another excuse to short it down.

Quote from Yahoo:
http://post.messages.yahoo.com/bbs?action=0&board=7076966&tid=isip&sid=7076966&mid=2...

UBS PaineWebber biotech analyst Andrew Gitkin retracted his statement made during a UBS sales call last week that he claimed to have spoken with half of the investigators in the ISIS Affinitak trial.

He now claims that he and his "associates" spoke with physicians that account for 100 patients.

He says that he only spoke with a few investigators and his associates did the majority of the calling.

My understanding is there are 616 patients so his initial 50% claim has suddenly dropped to 16%.

FWIW, I suspect the 100 patients is still a bloated figure. Most of the sites enrolled fewer than ten patients and there are likely over 100 sites. The investigators are bound by confidentiality agreements.

Draw your own conclusions.

Now if this jerk doesn't get jail time, there is no justice. He cost people a lot of money with a lie.